EUVIMEDОткрийте EUVIMED
Übersichtsarbeit

Biomarkers—A General Review

Jeffrey K Aronson, Robin E Ferner

Current Protocols in Pharmacology · 2017-03 · 76 (1)

DOI: 10.1002/cpph.19 ↗

At a glance

Übersichtsarbeit in Current Protocols in Pharmacology, published online on 2017-03-17. Written by Jeffrey K Aronson and 1 co-authors. Institution: Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Infirmary, Oxford, United Kingdom. Cited 343 times so far (Crossref); 47 references.

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

A biomarker is a biological observation that substitutes for and ideally predicts a clinically relevant endpoint or intermediate outcome that is more difficult to observe. The use of clinical biomarkers is easier and less expensive than direct measurement of the final clinical endpoint, and biomarkers are usually measured over a shorter time span. They can be used in disease screening, diagnosis, characterization, and monitoring; as prognostic indicators; for developing individualized therapeutic interventions; for predicting and treating adverse drug reactions; for identifying cell types; and for pharmacodynamic and dose‐response studies. To understand the value of a biomarker, it is necessary to know the pathophysiological relationship between the biomarker and the relevant clinical endpoint. Good biomarkers should be measurable with little or no variability, should have a sizeable signal to noise ratio, and should change promptly and reliably in response to changes in the condition or its therapy. © 2017 by John Wiley & Sons, Inc.

Subjects

MeSH terms (MEDLINE)

BiomarkersBiomarkers, PharmacologicalDiagnosisDose-Response Relationship, DrugDrug DiscoveryDrug-Related Side Effects and Adverse ReactionsHumansPharmacokineticsSensitivity and SpecificitySignal-To-Noise RatioTerminology as Topic

Author keywords

adverse drug reactionsbiomarkersdiagnosisdrug developmentdrug discoverymonitoring drug therapyscreeningsurrogate endpointssurrogate markers

Substances

BiomarkersBiomarkers, Pharmacological

Authors and institutions

  • Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Infirmary, Oxford, United Kingdom.
  • West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham, United Kingdom.
  • School of Medicine, University of Birmingham, Birmingham, United Kingdom.

Cite

APA

Aronson, J. K., & Ferner, R. E. (2017). Biomarkers—A General Review. Current Protocols in Pharmacology, 76(1). https://doi.org/10.1002/cpph.19

Vancouver

Aronson JK, Ferner RE. Biomarkers—A General Review. Current Protocols in Pharmacology. 2017;76(1). doi:10.1002/cpph.19

BibTeX
@article{Aronson2017,
  author = {Aronson, Jeffrey K and Ferner, Robin E},
  title = {Biomarkers—A General Review},
  journal = {Current Protocols in Pharmacology},
  year = {2017},
  volume = {76},
  number = {1},
  doi = {10.1002/cpph.19}
}
Start for free →